Australian Transportation Stock News

Technology One (ASX:TNE) has lifted its FY26 profit before tax growth guidance to 18% to 20% and raised recurring revenue growth targets to 16% to 18%, citing confidence in its SaaS+ pipeline. See our latest analysis for Technology One. That upgraded FY26 guidance comes as Technology One’s share price has risen 4.57% over the last day and 5.33% over the past week. The 90 day share price return of 13.39% and 1 year total shareholder return of a 10.49% decline highlight that recent momentum is...

29Metals (ASX:29M) has kicked off FY 2025 with first half revenue of A$271.0 million and basic EPS of A$0.026, with trailing twelve month revenue at A$566.6 million and EPS at A$0.018 as the business shifts back into profit on a full year basis. Over the past year, the company has seen revenue move from A$551.1 million to A$566.6 million on a trailing basis, while net income has turned from a A$177.6 million loss to a A$24.2 million profit. This signals a clear reset in earnings power and...

Objective (ASX:OCL) has reported its H1 2026 results with trailing 12 month revenue of A$128.9 million and basic EPS of A$0.388672, set against a year where earnings growth was 16.2%. The company has seen half year revenue move from A$59.7 million in H2 2024 to A$61.3 million in H1 2025 and A$62.2 million in H2 2025, while basic EPS has tracked A$0.157122, A$0.179 and A$0.192675 across those periods. These figures set up the latest numbers in the context of steadily expanding net profit...

MotorCycle Holdings (ASX:MTO) has put fresh numbers on the board for H1 2026, with trailing twelve month revenue at A$718.8 million and net income of A$19.8 million setting the backdrop for its latest earnings update. The company has seen revenue move from A$616.7 million to A$650.4 million and then to A$718.8 million over the past three reported trailing periods, while basic EPS over the last full year in the data sits in the mid 20 cent range. With net profit margins holding steady at 2.8%,...

Appen (ASX:APX) has put fresh numbers on the table, pairing its 2025 full year result with a new 2026 revenue outlook of US$270 million to US$300 million, giving investors updated earnings context. See our latest analysis for Appen. The new guidance appears to have landed in the middle of a sharp re‑rating, with Appen’s 30 day share price return of 72.69% and 90 day share price return of 160.84% contrasting with a 5 year total shareholder return decline of 86.48%. This suggests recent...

Clinuvel Pharmaceuticals (ASX:CUV) has put out its H1 2026 scorecard with investors looking closely at the recent revenue and EPS trends relative to its trailing performance. The company has seen total revenue move from A$55.4 million in H2 2024 to A$59.4 million in H2 2025, while basic EPS shifted from A$0.49 to A$0.44 over the same halves. This sets the backdrop for trailing 12 month figures that include revenue of A$96.9 million and basic EPS of A$0.65. With trailing net profit margins...

Betr Entertainment (ASX:BBT) has reported H1 2026 revenue of A$68.9 million with a net loss of A$32.7 million, equal to basic EPS of A$0.031, setting a clear earnings season marker for investors watching the betting and entertainment space. The company has seen first half revenue move from A$27.8 million in 2024 to A$68.9 million in 2025, while basic EPS shifted from A$0.0517 to A$0.031 and net loss widened from A$10.4 million to A$32.7 million over the same halves. The latest numbers are...

Bhagwan Marine (ASX:BWN) H1 2026 Earnings Snapshot Bhagwan Marine (ASX:BWN) has reported its H1 2026 numbers with trailing 12 month revenue of A$245.8 million and basic EPS of A$0.0239, setting the tone for how investors assess the latest half against its recent track record. The company has seen revenue move from A$159.4 million in H2 2024 to A$154.1 million in H1 2025 and A$128.9 million in H2 2025, while basic EPS shifted from A$0.0078 to A$0.0339 and then A$0.0133 over those same periods,...

CSL (ASX:CSL) has come into focus after out licensing its IL 6 antibody clazakizumab to Eli Lilly, securing A$100 million up front, along with future milestones and royalties tied to Lilly led development. See our latest analysis for CSL. That clazakizumab deal lands at a time when CSL’s share price has been under pressure, with a 30 day share price return showing an 18.55% decline, a 90 day share price return showing a 21.22% decline and a 1 year total shareholder return showing a 42.56%...

Nickel Industries (ASX:NIC) is back in focus after releasing its 2025 annual results. The company reported a narrower net loss, outlined detailed cost control efforts, and highlighted progress on the ENC HPAL Project with new equity partners. See our latest analysis for Nickel Industries. At a latest share price of A$1.015, Nickel Industries has seen a 40% 90 day share price return and a 38.1% 1 year total shareholder return, suggesting momentum has picked up following its earnings release,...

Why Monadelphous Group (ASX:MND) is in focus after its half year result Monadelphous Group (ASX:MND) is on investor radars after reporting record half year revenue and profit growth, backed by new contract wins and an increased fully franked interim dividend that signals strong cash generation. See our latest analysis for Monadelphous Group. The half year result has come alongside strong market interest, with Monadelphous Group’s 1 day share price return of 5.77% adding to a 90 day share...

Ansell Limited recently completed an on-market buyback of 1,372,236 shares for A$47.2 million and reported improved half-year results to December 31, 2025, with higher sales, net income of US$88.8 million, and basic EPS of US$0.615 from continuing operations. The company also lifted its interim dividend to US$0.266 per share, signaling management’s confidence and enhancing the role of capital returns in the investment case. We’ll now look at how the stronger interim profit performance and...

Guzman y Gomez Limited recently reported its half-year results to 31 December 2025, posting A$261.2 million in sales and A$10.58 million in net income, alongside higher earnings per share versus a year earlier. The company also declared a fully franked interim dividend of A$0.074 per share, reinforcing its capacity to return cash to shareholders while growing earnings. We’ll now examine how this earnings uplift and new interim dividend shape Guzman y Gomez’s existing investment narrative and...

G8 Education Limited has reported its full-year 2025 results, with sales of A$946.84 million, revenue of A$948.16 million and a net loss of A$303.31 million, reversing from a net profit a year earlier. The sharp swing from earnings per share of A$0.0838 to a basic loss per share of A$0.3924 raises fresh questions about the effectiveness and timing of the company’s turnaround efforts. We’ll now examine how this sizeable A$303.31 million net loss reshapes G8 Education’s existing investment...

Why Superloop’s latest earnings and ASX 300 entry matter for investors Superloop (ASX:SLC) has attracted fresh attention after joining the ASX 300 index and reporting half year 2025 results that show higher revenue and a move from loss to profit. See our latest analysis for Superloop. Superloop’s recent half year earnings, showing revenue of A$318.98 million and a move to A$5.11 million in net profit, alongside its entry into the ASX 300, have coincided with a 21.34% 1 month share price...

Emerald Resources (ASX:EMR) has drawn fresh attention after appointing Josh Redmond as Chief Operating Officer and releasing half year earnings showing A$257.04 million in sales and A$73.12 million in net income. See our latest analysis for Emerald Resources. At a share price of A$6.94, Emerald Resources has seen a 90 day share price return of 30.45% and a 1 year total shareholder return of 74.37%, which indicates recent momentum around the latest earnings update and leadership changes. If...

New Hope Corporation Limited has released unaudited operating results for the quarter and year to date ended January 31, 2026, showing 4,055,000 tons of ROM coal and 2,766,000 tons of saleable coal produced for the quarter, with year-to-date saleable production of 5,458,000 tons. An interesting detail is that year-to-date saleable coal output edged slightly higher than the prior year despite lower ROM production, pointing to efficiency and processing gains within the group’s operations. We...

Cobram Estate Olives Limited recently reported half-year results to 31 December 2025, with sales of A$116.13 million and revenue of A$120.04 million, alongside a net loss of A$11.93 million and higher losses per share than the prior period. The widening loss despite only a modest drop in sales and revenue highlights pressure on profitability and cost management at Cobram Estate Olives. With the company’s half-year loss widening, we’ll now examine how this result may influence Cobram Estate...

Australian United Investment Company Limited recently reported half-year results to December 31, 2025, with net income of A$27.26 million and basic earnings per share of A$0.22, and affirmed a fully franked ordinary dividend of A$0.17 per security payable on March 20, 2026, with an ex-dividend date of February 27, 2026 and record date of March 2, 2026. The combination of higher half-year profit and the continuation of a fully franked dividend stream highlights the company’s focus on...

Catalyst Metals Limited recently reported half-year results for the period ended 31 December 2025, with sales rising to A$267.85 million from A$177.97 million and net income increasing to A$59.70 million from A$46.29 million a year earlier. The uplift in both basic and diluted earnings per share from continuing operations underscores how the company converted higher revenue into stronger profitability over the half year. We’ll now examine how this earnings-driven improvement in profitability...

Why Telix’s latest guidance is attracting fresh attention Telix Pharmaceuticals (ASX:TLX) is back on many investors’ radar after the company issued 2026 revenue guidance of US$950 million to US$970 million and highlighted strong 2025 results supported by Gozellix uptake and Medicare reimbursement. See our latest analysis for Telix Pharmaceuticals. That guidance and the recent Gozellix and TLX101 Px updates have arrived after a volatile spell, with a 1 day share price return of 10.87% and a 1...

Acusensus (ASX:ACE) H1 2026 Earnings Snapshot Acusensus (ASX:ACE) has just put fresh numbers on the table for H1 2026, with the latest trailing twelve month revenue at A$70.9 million and a basic EPS loss of A$0.164553. This sets the tone for how investors will read the new half-year result against a still loss-making profile. The company has seen revenue move from A$24.9 million in H2 2024 to A$28.8 million in H1 2025 and A$30.6 million in H2 2025. Basic EPS has ranged from a loss of...

Bendigo and Adelaide Bank (ASX:BEN) has just released half year results alongside an affirmed ordinary dividend. This combination often prompts investors to reassess income potential and the bank’s current share pricing. See our latest analysis for Bendigo and Adelaide Bank. At a share price of A$10.93, Bendigo and Adelaide Bank has seen a 1-day share price return of 1.11% and a 90-day share price return of 6.74%. Its 1-year total shareholder return of 7.99% and 5-year total shareholder...

Minerals 260 (ASX:MI6) has agreed to a A$220 million funding package with Franco-Nevada to advance its Bullabulling gold project in Western Australia, including a higher project royalty and a A$50 million equity investment. See our latest analysis for Minerals 260. The Franco Nevada funding news lands after a strong run in Minerals 260’s share price, with a 7 day share price return of 58.33% and a 90 day share price return of 95.59%, while the 3 year total shareholder return of 107.81% points...